Insiders · Profile

Jewell Christopher M

Chief Scientific Officer at Cartesian Therapeutics. Filing since 14 Nov 2024. CIK 0002000226

Company
Date
Role
Action
Shares
Amount
Of holding
6 Jan 2025
Chief Scientific Officer
Sold at will
1,286
$21.65K
2.3%
3 Jan 2025
Chief Scientific Officer
Sold at will
1,264
$21.14K
2.3%
15 Nov 2024
Chief Scientific Officer
Sold at will
16,065
$274.09K
38.2%
14 Nov 2024
Chief Scientific Officer
Sold at will
36,050
$600.95K
58.2%
4 decisions on file.